Sensory gating in subjects at ultra high risk for developing a psychosis before and after a first psychotic episode

World Journal of Biological Psychiatry

Volumn 16, Issue 1, 2015, Pages 12-21

  Van Tricht, Mirjam J ^a   Nieman, Dorien H ^a   Koelman, Johannes T M ^a   Mensink, Arianne J M ^a   Bour, Lo J ^a   Van Der Meer, Johan N ^a   Van Amelsvoort, Thérèse A ^a,b   Linszen, Don H ^a   De Haan, Lieuwe ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Psychopathology; Psychosis prediction; Schizophrenia; Sensory gating; Ultra high risk subjects

Indexed keywords

ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; LITHIUM CARBONATE; METHYLPHENIDATE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BRIEF PSYCHOTIC DISORDER; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; PSYCHOSIS; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SCHIZOPHRENIFORM DISORDER; SENSORY GATING; ULTRA HIGH RISK SUBJECT; ADOLESCENT; CASE CONTROL STUDY; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; FEMALE; LONGITUDINAL STUDY; MALE; MENTAL DISEASE; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTIC DISORDERS; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; PATIENT OUTCOME ASSESSMENT; PSYCHIATRIC STATUS RATING SCALES; PSYCHOPATHOLOGY; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SENSORY GATING; YOUNG ADULT;

EID: 84920817604     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2012.680911     Document Type: Article

References (46)

1. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. 1982. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17:639-654.
2. Adler LE, Olincy A, Cawthra EM, McRae KA, Harris JG, Nagamoto HT, et al. 2004. Varied effects of atypical neuroleptics on P50 auditory gating in schizophrenia patients. Am J Psychiatry 161:1822-1828.
3. Arnfred S. 2006. Exploration of auditory P50 gating in schizophrenia by way of difference waves. Behav Brain Funct 2:6.
4. Blumenfeld LD, Clementz BA. 2001. Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG. Clin Neurophysiol 112:1650-1659.
5. Boutros NN, Belger A. 1999. Midlatency evoked potentials attenuation and augmentation refl ect different aspects of sensory gating. Biol Psychiatry 45:917-922.
6. Boutros NN, Overall J, Zouridakis G. 1991. Test-retest reliability of the P50 mid-latency auditory evoked response. Psychiatry Res 39:181-192.
7. Boutros NN, Korzyuko O, Oliwa G, Feingold A, Campbell D, McClain-Furmanski D, et al. 2004a. Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report. Schizophr Res 70:303-313.
8. Boutros NN, Korzyukov O, Jansen B, Feingold A, Bell M. 2004b. Sensory gating defi cits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 126:203-215.
9. Boutros, NN, Gooding D, Sundaresan K, Burroughs S, Johanson CE. 2006. Cocaine-dependence and cocaine-induced paranoia and mid-latency auditory evoked responses and sensory gating. Psychiatry Res 145:147-154.
10. Bramon E, Rabe-Hesketh S, Sham P, Murray RM, Frangou S. 2004. Meta-analysis of the P300 and P50 waveforms in schizophrenia. - Shizophr Res 70:315-329.
11. Bramon E, Shaikh M, Broome M, Lappin J, Bergé D, Day F, et al. 2008. Abnormal P300 in people with high risk of developing psychosis. Neuroimage 41:553-560.
12. Brenner CA, Kieffaber PD, Clementz BA, Johannesen JK, Shekhar A, O'Donnell BF, et al. 2009. Event-related potential abnormalities in schizophrenia: A failure to "gate in" salient information? Schizophr Res 113:332-338.
13. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, et al. 2008. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 64:376-384.
14. Cadenhead KS, Light GA, Shafer KM, Braff DL. 2005. P50 Suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biol Psychiatry 57:1504-1509.
15. Campanella S, Guerit JM. 2009. How clinical neurophysiology may contribute to the understanding of a psychiatric disease such as schizophrenia. Neurophysiol Clin 39:31-39.
16. Clementz BA, Geyer MA, Braff DL. 1998. Multiple site evaluation of P50 suppression among schizophrenia and normal comparison subjects. Schizophr Res 30:71-80.
17. de Wilde OM, Bour LJ, Dingemans PM, Koelman JHTM, Linszen, DH. 2007. A meta-analysis of P50 studies in patients with schizophrenia and relatives: Differences in methodology between research groups. Schizophr Res 97:137-151.
18. Foxe J, Yeap S, Snyder A, Kelly S, Thakore J, Molholm S. 2010. The N1 auditory evoked potential component as an endophenotype for schizophrenia: high-density electrical mapping in clinically unaffected fi rst-degree relatives, fi rst-episode, and chronic schizophrenia patients. Eur Arch Psychiatry Clin Neurosci 261:331-339.
19. Fuerst, DR, Gallinat J, Boutros NN. 2007. Range of sensory gating values and test-retest reliability in normal subjects. Psychophysiology 44:620-626.
20. Gratton G, Coles M, Donchin E. 1982. A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55:468-484.
21. Jerger K, Biggins C, Fein G. 1992. P50 suppression is not affected by attentional manipulations. Biol Psychiatry 31:365-377.
22. Johannesen JK, Kieffaber PD, O'Donnell BF, Shekhar A, Evans JD, Hetrick,WP. 2005. Contributions of subtype and spectral frequency analyses to the study of P50 ERP amplitude and suppression in schizophrenia. Schizophr Res 78:269-284.
23. Judd LL, McAdams L, Budnick B, Braff DL., 1992. Sensory gating defi cits in schizophrenia: new results. Am J Psychiatry 149:488-493.
24. Kay SR, Fiszbein A, Opler LA. 1987. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261-276.
25. Knott V, Millar A, Fisher D. 2009. Sensory gating and source analysis of the auditory P50 in low and high suppressors. Neuroimage 44:992-1000.
26. Light GA, Geyer MA, Clementz BA, Cadenhead KS, Braff DL. 2000. Normal P50 suppression in schizophrenia patients treated with atypical antipsychotic medications. Am J Psychiatry 157:767-771.
27. McGorry PD, Yung AR, Phillips LJ. 2003. The "close-in" or ultra high-risk model: a safe and effective strategy for research and clinical intervention in prepsychotic mental disorder. Schizophr Bull 29:771-790.
28. Miller TJ, McGlashan TH, Rosen JL, Cadenhead K, Ventura J, McFarlane W. 2003. Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull 29:703-715.
29. Myles-Worsley M, Ord L, Blailes F, Ngiralmau H, Freedman R. 2004. P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia. Biol Psychiatry 55:663-667.
30. Olincy A, Braff DL, Adler AE, Cadenhead KS, Calkins ME, Dobie DJ, et al. 2010. Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia. Schizophr Res 119:178-82.
31. Patterson JV, Jin Y, Gierczak M, Hetrick WP, Potkin S, Bunney WEJ, et al. 2000. Effects of temporal variability on p50 and the gating ratio in schizophrenia: a frequency domain adaptive fi lter single-trial analysis. Arch Gen Psychiatry 57:57-64.
32. Patterson JV, Hetrick WP, Boutros NN, JinY, Sandman C, Stern H, et al. 2008. P50 sensory gating ratios in schizophrenics and controls: A review and data analysis. Psychiatry Res 158:226-247.
33. Perneger TV., 1998. What's wrong with Bonferroni adjustments. BMJ 316:1236-1238.
34. Potter D, Summerfelt A, Gold J, Buchanan RW. 2006. Review of clinical correlates of p50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull 32:692-700.
35. Rentzsch J, Jockers-Scherübl MC, Boutros NN, Gallinat J. 2008. Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol 67:81-90.
36. Rothman KJ. 1990. No adjustments are needed for multiple comparisons. Epidemiology 1:43-46.
37. Schmand BA, Bakker D, Saan R, Louman J. 1991. The Dutch Reading Test for Adults: a measure of premorbid intelligence level. Tijdschr Gerontol Geriatr 22:15-19.
38. Schulze KK, Hall MH, McDonald C, Marshall N, Walshe M, Murray RM, et al. 2007. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry 62:121-128.
39. Smith DA, Boutros NN, Schwarzkopf SB. 1994. Reliability of P50 auditory event-related potential indices of sensory gating. Psychophysiology 31:495-502.
40. Spitzer RL, Williams JB, Gibber M, First MB. 1992. The Structured Clinical Interview for DSM-III-R (SCID). I: History, rationale, and description. Arch Gen Psychiatry 49:624-629.
41. van Tricht MJ, Nieman DH, Koelman JTHM, van der Meer JN, Bour LJ, de Haan L, et al. 2010. Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol Psychiatry 68:642-648.
42. van Tricht MJ, Nieman DH, Koelman JHTM, Bour LJ, van der Meer JN, van Amelsvoort TA, et al. 2011. Auditory ERP components before and after transition to a first psychotic episode. Biol Psychol 87:350-357.
43. Wittchen HU. 1994. Reliability and validity studies of the WHO-Composite International Diagnostic Interview (CIDI): A critical review. J Psychiatr Res 28:57-84.
44. Yung AR. 2003. Commentary: The schizophrenia prodrome: a high-risk concept. Schizophr Bull 29:859-865.
45. Yung AR, Stanford C, Cosgrave E, Killackey E, Phillips L, Nelson B, et al. Testing the Ultra High Risk (prodromal) criteria for the prediction of psychosis in a clinical sample of young people. Schizophr Res 84:57-66.
46. Yung AR, Yuen HP, Berger G, Francey S, HungTC, Nelson B, et al. 2007. Declining transition rate in Ultra High Risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33:673-681.